13G Filing: Armistice Capital and Apricus Biosciences Inc. (APRI)

Page 10 of 10

Page 10 of 10 – SEC Filing

Exhibit A

AGREEMENT

The undersigned
agree that this Schedule 13G dated September 20, 2017 relating to the Common Stock, par value $.001, of Apricus Biosciences, Inc.
shall be filed on behalf of the undersigned.

Armistice Capital, LLC

By: /s/ Steven Boyd

__________________________

Steven Boyd

Managing Member

Armistice Capital Master Fund Ltd.

By: /s/ Steven Boyd

__________________________

Steven Boyd

Director

/s/ Steven Boyd

__________________________

Steven Boyd

Follow Seelos Therapeutics Inc. (NASDAQ:SEEL)

Page 10 of 10